Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kava in generalized anxiety disorder
NCT04565145Phase 2Completed
- Sponsor
- University of Florida
- Start
- Apr 2021
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in generalized anxiety disorder (GAD) (2 arms), sponsored by University of Florida. Primary endpoint: Mean PRKACA Change at 1 week. Started Apr 2021; status: completed.
02
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT04565145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04565145.